# Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease

> **NCT04780399** · PHASE2 · UNKNOWN · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 216 (estimated)

## Conditions studied

- Alzheimer Disease
- Yangxue Qingnao Pills
- Randomized

## Interventions

- **DRUG:** Yangxue Qingnao pills
- **DRUG:** Yangxue Qingnao pills
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04780399
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-09
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-12-30
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780399, "Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04780399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*